ArticleClinical & experimental metastasis2014

Class III β-tubulin overexpression within the tumor microenvironment is a prognostic biomarker for poor overall survival in ovarian cancer patients treated with neoadjuvant carboplatin/paclitaxel.

Dana M Roque et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.